@prefix this: . @prefix sub: . @prefix np: . @prefix rdf: . @prefix xsd: . @prefix rdfs: . @prefix biolink: . @prefix ns1: . @prefix prov: . @prefix npx: . sub:Head { this: np:hasAssertion sub:assertion; np:hasProvenance sub:provenance; np:hasPublicationInfo sub:pubInfo; a np:Nanopublication . } sub:assertion { a biolink:Disease . sub:association rdf:object ; rdf:predicate biolink:treats; rdf:subject ; a rdf:Statement; rdfs:label "The on‐label indication for Brintellix is depression; we identified the following off‐label indications: schizophrenia, episodic mood disorders, anxiety disorders, personality disorders, bipolar depression, post‐traumatic stress disorder, and chronic pain."; biolink:has_population_context sub:context; biolink:provided_by ; biolink:publications ; biolink:relation . sub:context a biolink:Cohort; rdfs:label "Adults" . a biolink:Drug . } sub:provenance { sub:assertion prov:generatedAtTime "2021-08-17T12:40:51.128740"^^xsd:dateTime . } sub:pubInfo { sub:sig npx:hasAlgorithm "RSA"; npx:hasPublicKey "MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB"; npx:hasSignature "CzgYRYv6j0AWe2mFhZSyNrKm8L8qYKsnE9l1ivgvI8dcldt1KMui+rGKlytLNbCCAwK+yTi6oKUB9nw3dHzvzMtkUKe9Gu1TYwc3oy3/O0RaghKhJ2SifdVhJtNjNfpysd/tuqFkQGXUsAko9MqlJ5TWGAUhiAi6T0pR9L/+t/E="; npx:hasSignatureTarget this: . this: prov:generatedAtTime "2021-08-17T12:40:51.128740"^^xsd:dateTime; prov:wasAttributedTo ; ns1:wasCreatedFromTemplate . }